According to 2016 WHO criteria, except for diffuse astrocytic and oligodendroglial tumors, the IDH1 genotypes and status of chromosome arms 1p and 19q have been incorporated into the classification of gliomas [3, 17]. This evidence concerns the gene IDH1 and central nervous system cancer.